Ensign Peak Advisors, Inc Horizon Therapeutics Public LTD CO Transaction History

Ensign Peak Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $6.47 Million - $11.8 Million	-103,758 Reduced 96.57%	3,681 $418,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $1.51 Million - $2.16 Million	-25,563 Reduced 19.22%	107,439 $6.65 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $3.58 Million - $5.24 Million	45,038 Added 51.2%	133,002 $10.6 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $1.61 Million - $2.05 Million	-18,649 Reduced 17.49%	87,964 $9.26 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $7.33 Million - $8.92 Million	74,407 Added 231.03%	106,613 $11.5 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $2.3 Million - $2.76 Million	24,997 Added 346.75%	32,206 $3.53 Million
Q1 2021 May 12, 2021	SELL	$71.83 - $95.48 $8.65 Million - $11.5 Million	-120,358 Reduced 94.35%	7,209 $664,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $493,053 - $621,026	-7,359 Reduced 5.45%	127,567 $9.33 Million
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $583,118 - $843,900	-10,558 Reduced 7.26%	134,926 $10.5 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $880,028 - $1.66 Million	-29,140 Reduced 16.69%	145,484 $8.09 Million
Q1 2020 May 11, 2020	BUY	$24.87 - $38.56 $1.5 Million - $2.32 Million	60,264 Added 52.7%	174,624 $5.17 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $2.91 Million - $4.19 Million	114,360 New	114,360 $4.14 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.